Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine (Q35987793)

11 August 2017

1 reference

title

Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine (English)

1 reference

11 August 2017

1 reference

1 reference

1 reference

1

Robert Belshe

1 reference

11 August 2017

Min-Shi Lee

2

1 reference

11 August 2017

Robert E Walker

series ordinal

3

1 reference

11 August 2017

Jeffrey Stoddard

series ordinal

4

1 reference

11 August 2017

Paul M Mendelman

series ordinal

5

1 reference

11 August 2017

language of work or name

1 reference

1 December 2004

1 reference

Expert Review of Vaccines

11 August 2017

1 reference

11 August 2017

3

1 reference

11 August 2017

6

1 reference

11 August 2017

643-654

1 reference

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

11 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.643

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.643

Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.643

Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.643

Determinants of immunity to influenza infection in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.643

Influenza at Christ's Hospital: March, 1974.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.643

Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.643

Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.643

Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.643

Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.643

Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.643

Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.643

21 January 2018

Identifiers

DOI

10.1586/14760584.3.6.643

1 reference

11 August 2017

1 reference